# OnCo record paper-juliet-tisagenlecleucel-dlbcl-nejm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-juliet-tisagenlecleucel-dlbcl-nejm-2019" ;
schema:name "JULIET: tisagenlecleucel for adults with relapsed or refractory diffuse large B-cell lymphoma"@en ;
schema:description "In adults with aggressive lymphoma after at least two prior treatments, tisagenlecleucel produced responses in 52% and complete responses in 40%, most of which lasted."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2019"^^xsd:gYear ;
schema:author "Schuster SJ, Bishop MR, Tam CS, et al." ;
onco:related , , ;
onco:cancers ;
onco:technologies ;
onco:targets ;
onco:drugs ;
onco:companies ;
onco:institutions ;
onco:terms , , ;
onco:trials , ;
onco:bottlenecks ;
onco:journals .